Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options - Archive ouverte HAL
Article Dans Une Revue European Respiratory Review Année : 2019

Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options

Résumé

Central sleep apnoea (CSA) including periodic breathing is prevalent in more than one-third of patients with heart failure and is highly and independently associated with poor outcomes. Optimal treatment is still debated and well-conducted studies regarding efficacy and impact on outcomes of available treatment options are limited, particularly in cardiac failure with preserved ejection fraction. While continuous positive airway pressure and oxygen reduce breathing disturbances by 50%, adaptive servoventilation (ASV) normalises breathing disturbances by to controlling the underlying mechanism of CSA. Results are contradictory regarding impact of ASV on hard outcomes. Cohorts and registry studies show survival improvement under ASV, while secondary analyses of the large SERVE-HF randomised trial showed an excess mortality in cardiac failure with reduced ejection fraction. The current priority is to understand which phenotypes of cardiac failure patients may benefit from treatment guiding individualised and personalised management.
Fichier principal
Vignette du fichier
190084.full.pdf (433.65 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03680738 , version 1 (03-06-2022)

Identifiants

Citer

Winfried Randerath, Oana Deleanu, Sofia Schiza, Jean-Louis Pepin. Central sleep apnoea and periodic breathing in heart failure: prognostic significance and treatment options. European Respiratory Review, 2019, 28 (153), pp.190084. ⟨10.1183/16000617.0084-2019⟩. ⟨hal-03680738⟩

Collections

INSERM UGA
15 Consultations
32 Téléchargements

Altmetric

Partager

More